SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-130395
Filing Date
2023-05-01
Accepted
2023-05-01 16:07:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d438047ddefa14a.htm DEFA14A 14915
2 GRAPHIC g438047g00x01.jpg GRAPHIC 168926
3 GRAPHIC g438047g00x02.jpg GRAPHIC 39184
  Complete submission text file 0001193125-23-130395.txt   293172
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39692 | Film No.: 23873619
SIC: 2836 Biological Products, (No Diagnostic Substances)